Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 6/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | ALDH2 | P05091 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.50 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | RARB | P10826 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 2/20 | 0.46 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2901627 | 1.00 | APP (0.58) | APPL3MBTL1ALDH2ALDH1A1MEN1 | |
| SCHEMBL1412773 | 0.94 | APP (0.64) | APPL3MBTL1ALDH2ALDH1A1MEN1 | |
| SCHEMBL1815639 | 0.94 | APP (0.64) | APPL3MBTL1ALDH2ALDH1A1MEN1 | |
| SCHEMBL1412728 | 0.94 | APP (0.64) | APPL3MBTL1ALDH2ALDH1A1MEN1 | |
| SCHEMBL1412776 | 0.94 | APP (0.64) | APPL3MBTL1ALDH2ALDH1A1MEN1 | |
| SCHEMBL4613135 | 0.92 | L3MBTL1 (0.61) | APPL3MBTL1ALDH2ALDH1A1MEN1 | |
| SCHEMBL4354892 | 0.92 | APP (0.61) | APPALDH2LMNARARBLTA4H | |
| SCHEMBL2924048 | 0.90 | ALDH1A1 (0.58) | APPALDH2ALDH1A1CYP3A4SMN1; SMN2 | |
| SCHEMBL14901579 | 0.89 | LTA4H (0.59) | APPL3MBTL1ALDH2ALDH1A1MEN1 | |
| SCHEMBL466232 | 0.88 | APP (0.65) | APPL3MBTL1ALDH1A1MEN1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130109758-A1 | BISPHENOL DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2013-05-02 | — | — | US | disclosed |
| US-20130109758-A1 | BISPHENOL DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2013-05-02 | — | — | US | disclosed |
| EP-1636209-B1 | EPOXY COMPOUND AND CURED EPOXY RESIN PRODUCT | SUMITOMO CHEMICAL CO (JP) | 2010-08-11 | — | — | EP | disclosed |
| US-7279574-B2 | Epoxy compound and cured epoxy resin product | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-09 | — | — | US | disclosed |
| US-20060159929-A1 | Epoxy compound and cured epoxy resin product | HITACHI, LTD. (JP) | 2006-07-20 | — | — | US | disclosed |
| EP-1636209-A1 | EPOXY COMPOUND AND CURED EPOXY RESIN PRODUCT | Sumitomo Chemical Company, Limited (JP) | 2006-03-22 | — | — | EP | disclosed |
| WO-2004113327-A1 | EPOXY COMPOUND AND CURED EPOXY RESIN PRODUCT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130109758-A1 | BISPHENOL DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE | SHBG, KLK3, HSD17B11 | APP 4784/4885L3MBTL1 2335/4885ALDH2 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.